BlackRock Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.3M	Buy	161,568 +27,059	+20%	+$2.06M	0.01%	980
2016 Q3	$11.2M	Buy	134,509 +458	+0.3%	+$38.4K	0.01%	931
2016 Q2	$11.1M	Buy	134,051 +4,628	+4%	+$381K	0.01%	893
2016 Q1	$9.83M	Sell	129,423 -29,397	-19%	-$2.18M	0.01%	937
2015 Q4	$12.8M	Sell	158,820 -39,509	-20%	-$2.85M	0.02%	804
2015 Q3	$12.6M	Sell	198,329 -2,222	-1%	-$160K	0.02%	787
2015 Q2	$14.1M	Buy	200,551 +10,811	+6%	+$800K	0.02%	764
2015 Q1	$15M	Buy	189,740 +5,763	+3%	+$425K	0.02%	712
2014 Q4	$11.7M	Buy	183,977 +2,814	+2%	+$176K	0.02%	840
2014 Q3	$10.8M	Sell	181,163 -1,609	-0.9%	-$92.1K	0.02%	875
2014 Q2	$9.78M	Buy	182,772 +47,733	+35%	+$2.62M	0.01%	981
2014 Q1	$8.15M	Sell	135,039 -2,713	-2%	-$158K	0.01%	1057
2013 Q4	$7.31M	Sell	137,752 -3,493	-2%	-$175K	0.01%	1098
2013 Q3	$6.53M	Buy	141,245 +12,785	+10%	+$587K	0.01%	1113
2013 Q2	$5.27M	Buy	+128,460	New	+$5.5M	0.01%	1181